Stocks · Health care · Pharmaceutical Preparations

GALECTIN THERAPEUTICS INC

GALT Clue Score21
United States Fiscal year ends December CIK 0001133416 Results filed 14 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Kary Eldred
6 Feb 2026
Director
Buy
300
$2.70
$810.00
Kary Eldred
23 Dec 2025
Director
Buy
700
$3.73
$2.61K
Kevin D Freeman
23 Dec 2025
Director
Buy
5,500
$3.55
$19.51K
Kary Eldred
23 Dec 2025
Director
Buy
700
$3.73
$2.61K

What was left out

Form 4 filings counted 43
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 43
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 35,181,445
History held since 9 Feb 2007